Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 848 Carcinoma, Non-Small-Cell Lung 549 Neoplasms 510 Prostatic Neoplasms 501 Lung Neoplasms 312 Colorectal Neoplasms 307 Multiple Myeloma 292 Neoplasm Metastasis 250 Melanoma 241 Ovarian Neoplasms 215 Leukemia, Myeloid, Acute 208 Pancreatic Neoplasms 207 Squamous Cell Carcinoma of Head and Neck 173 Carcinoma, Renal Cell 165 Recurrence 162 Stomach Neoplasms 161 Carcinoma, Hepatocellular 160 Lymphoma 156 Brain Neoplasms 152 Glioblastoma 147 Uterine Cervical Neoplasms 144 Lymphoma, Non-Hodgkin 141 Head and Neck Neoplasms 140 Triple Negative Breast Neoplasms 136 Leukemia, Lymphocytic, Chronic, B-Cell 136 Urinary Bladder Neoplasms 135 Precursor Cell Lymphoblastic Leukemia-Lymphoma 132 Colonic Neoplasms 115 Hematologic Neoplasms 113 Lymphoma, Follicular 112

Interventions

Interleukin-15 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × High-risk Leukemias × Clear all

NCT05304754 2025-04-06

PHINK

Instituto de Investigación Hospital Universitario La Paz

Phase 1/2 Active not recruiting

Other hematologic neoplasm

High-risk Leukemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡